INVES BIOFARM attended FARMAFORUM on September 17th and 18th, the most significant gathering for the Pharmaceutical Industry in Spain.
We sincerely thank the organizers for the excellent execution of the event. The two-day conference served as the nerve center for debate and learning around the Biotechnology and Cosmetics industries, as well as the field of medical devices. This was a fundamental event for sharing knowledge and establishing new strategic collaborations.
The INVES BIOFARM research team is proud to announce our involvement in another project of excellence in innovation.
Our primary goal is the development of a highly effective and safe product for the treatment of knee joint lesions (or articular injuries). We aim to address osteoarticular pathologies through an innovative solution that offers regenerative benefits.
The core of this innovation lies in the implementation of an advanced encapsulation method to incorporate new technologies into the final formulation. This approach guarantees the stability, efficacy, and controlled release of the active principles, thereby maximizing their therapeutic potential.
The project is supported by a high-level scientific and technological consortium, composed of:
Inves Biofarm (Coordinator) Leitat (Technological Center) VHIR (Vall d’Hebron Research Institute)
This collaboration is based on a long and fruitful track record of joint success, ensuring the integration of expertise in research, technological development, and clinical application.
The INVES BIOFARM team is currently carrying out the VAGINEF project in collaboration with Leitat and the Vall d’Hebron Hospital in Barcelona.
The central goal of the project is the development of an effective and safe topical product designed for the treatment of vaginal atrophy. This development seeks to significantly improve the quality of life for women suffering from this condition.
The crucial technological innovation lies in the use of a protein stabilization technology patented by the company. This method allows the protein activity to be preserved intact for a longer period, thereby ensuring maximum efficacy.
The project benefits from the multidisciplinary expertise of its collaborators:
INVES BIOFARM, Providing the stabilization technology and project coordination.
Leitat, A key technological center and Vall d’Hebron Hospital in Barcelona, Guaranteeing clinical validation and the practical application of the research.
We are now halfway through the CRONISAN project, which aims to develop an effective formulation incorporating growth factors for treating chronic ulcers. These growth factors will be stabilised using a stabilisation patent to guarantee their effectiveness over time.
The consortium comprises Inves Biofarm (the coordinator), UGR and Leitat, with whom we have a long and successful history of collaboration.
This project forms part of the PCPP2022 programme and has been funded under reference CPP2022-009544.
Instituto de Investigación Biotecnológica, Farmacéutica y Medicamentos Huérfanos, S.L. has benefited from the Mentoring and Support Programme for the Internationalisation of SMEs. The company has used these funds to co-finance dissemination and promotional materials, specifically for the stand at the 2024 BeautyWorld Middle East fair. The Middle East region is a dynamic market for the beauty and wellness industry and a prime destination for growth and innovation. Thanks to this programme, we have had the opportunity to network with some of the industry’s top leaders and expand our existing contacts in the region.
INVES BIOFARM, a leader in biotechnological solutions, is taking a firm step towards sustainability with the installation of 130 photovoltaic modules on its facilities. This initiative, which will generate 100,000 kWh of clean energy per year, reinforces the company’s commitment to protecting the environment and reducing its carbon footprint.
The new photovoltaic plant will allow INVES BIOFARM to cover a significant part of its energy needs with renewable energy. It is estimated that this installation will avoid the emission of approximately 32 tons of CO2 per year, equivalent to planting more than 900 trees.
At INVES BIOFARM, we believe that innovation and sustainability go hand in hand. This investment in solar energy not only optimises our processes, but also contributes to a greener and more responsible future.
The installation of photovoltaic modules is part of the company’s overall strategy to align with the Sustainable Development Goals (SDGs), in particular SDG 7 (affordable and clean energy) and SDG 13 (climate action). Furthermore, this initiative positions INVES BIOFARM as a benchmark in the biotechnology sector, demonstrating that it is possible to combine operational excellence with environmental responsibility.
INVES BIOFARM invites its partners, customers and the community to join this commitment to a sustainable future and reaffirms its commitment to the environment.
Inves Biofarm once again confirms its presence at COSMOPROF BOLOGNA 2025, the world’s most influential event dedicated to all facets of the cosmetics and skin care industry.
The 56th edition of Cosmoprof Worldwide Bologna took place from Thursday 20 to Sunday 23 March 2025.
Over 240,000 visitors from 150 countries. Over 3000 exhibitors from 69 markets. Cosmoprof Bologna is the world reference and meeting point for manufacturers and professionals in the cosmetics sector.
It is the place where companies do business and the perfect stage to present innovative product launches and new solutions.
During these three days, Inves Biofarm took the opportunity to make contacts with industry professionals and distributors, to present products and to explore new business opportunities.
We are grateful for this enriching experience, as our time at Cosmoprof Bologna 2025 not only reflects the vitality of the industry, but also demonstrates the commitment to excellence and innovation that we instil at Inves Biofarm.
We are pleased to announce that we had the opportunity to participate in the 50th edition of Arab Health, the world’s leading trade fair for healthcare technology and medicine! Thanks to the encouragement of Andalucía Trade, Inves Biofarm took part in this flagship event, which was held at the Dubai International Convention and Exhibition Centre from 27 to 31 January.
In a market that is expected to grow by 6.9% until 2026, this exhibition is a strategic gateway to expand our presence in the region. We are proud to be among the leading companies in the healthcare technology sector in Andalusia, exploring new business opportunities and consolidating our position as a benchmark for innovation and quality.
With more than 3,800 exhibitors and 60,000 visitors from 180 countries, Arab Health is much more than an exhibition: it is an epicentre of connections, knowledge and advances in medicine. We are excited about the opportunities this global platform offers to forge new partnerships and strengthen existing ones.
Inves Biofarm is pleased to announce the publication of the study that successfully supports the successful performance of an innovative cream using raw materials derived from up-cycling. The study used a polyphenolic extract from olive pomace – a by-product of olive oil production – encapsulated with sh-oligopeptide-1 using spray-drying technology. Clinical trials showed significant improvements in skin hydration, elasticity and barrier function after just one week of application.
We would like to thank our research team and the study participants, AINIA, UGR and the Dermatology Department of the Hospital Virgen de las Nieves in Granada for their dedication and commitment. At Inves Biofarm, we remain committed to providing scientifically backed, high quality skin care solutions.
We would like to announce that Inves Biofarm was present at the 27th edition of Cosmoprof Asia 2024, held in Hong Kong from 13th to 15th November. This event, which gathered more than 60,000 visitors, 2,400 exhibitors and representatives from 17 different countries, consolidated its position as the leading international B2B beauty trade fair in Asia.
During these three days, Inves Biofarm took the opportunity to network with industry experts and distributors, raise product awareness and explore new business opportunities.
We are grateful for this enriching experience, as our time at Cosmoprof Asia 2024 not only reflects the vitality of the industry, but also demonstrates Inves Biofarm’s commitment to excellence and innovation.
